| Dr Adriana Saker, MD | |
|
5130 Linton Blvd, Suite D-1, Delray Beach, FL 33484-6596 | |
| (561) 499-0232 | |
| (561) 499-0335 |
| Full Name | Dr Adriana Saker |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 37 Years |
| Location | 5130 Linton Blvd, Delray Beach, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760435671 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME68009 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina Macula Specialists Of Miami Llc | 7012156144 | 22 |
News Archive
New research says chemotherapy often fails to totally eliminate breast cancer because it does not knock out breast cancer stem cells.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
Retrophin, Inc. today announced that it will acquire privately-held Kyalin Biosciences, Inc., an early-stage company based in San Diego, CA, that is developing therapies targeting the core symptoms of autism and related conditions.
› Verified 4 days ago
| Entity Name | Retina Macula Specialists Of Miami Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982946612 PECOS PAC ID: 7012156144 Enrollment ID: O20130620000268 |
News Archive
New research says chemotherapy often fails to totally eliminate breast cancer because it does not knock out breast cancer stem cells.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
Retrophin, Inc. today announced that it will acquire privately-held Kyalin Biosciences, Inc., an early-stage company based in San Diego, CA, that is developing therapies targeting the core symptoms of autism and related conditions.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Adriana Saker, MD 5130 Linton Blvd, Suite D-1, Delray Beach, FL 33484-6596 Ph: (561) 499-0232 | Dr Adriana Saker, MD 5130 Linton Blvd, Suite D-1, Delray Beach, FL 33484-6596 Ph: (561) 499-0232 |
News Archive
New research says chemotherapy often fails to totally eliminate breast cancer because it does not knock out breast cancer stem cells.
NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare and connectivity solutions, today commented that the Notice of Proposed Rule Making issued last week on electronic health record (EHR) incentive programs moves the healthcare industry closer to securing American Recovery and Reinvestment Act (ARRA) stimulus payments for healthcare IT adoption.
The U.S. Food and Drug Administration today issued two comprehensive evaluations containing recommendations that address three key objectives of the agency's public health mission as it relates to medical devices – foster device innovation, create a more predictable regulatory environment, and enhance device safety.
Retrophin, Inc. today announced that it will acquire privately-held Kyalin Biosciences, Inc., an early-stage company based in San Diego, CA, that is developing therapies targeting the core symptoms of autism and related conditions.
› Verified 4 days ago
Dr. Mark Alan Werner, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16201 S Military Trl, Delray Beach, FL 33484 Phone: 561-498-8100 Fax: 561-498-8188 | |
Dr. Bruce A Segal, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5258 Linton Blvd, Delray Beach, FL 33484 Phone: 561-498-3664 Fax: 561-496-2493 | |
Eric J Rothchild, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16244 Military Trl, Suite 690, Delray Beach, FL 33484 Phone: 561-495-2811 Fax: 561-495-9538 | |
Dr. Steven Ira Rosenfeld, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 16201 Military Trl, Delray Beach, FL 33484 Phone: 561-498-8100 Fax: 561-498-8188 | |
Robert W Raden, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5130 Linton Blvd, F7, Delray Beach, FL 33484 Phone: 561-499-8830 Fax: 561-637-8077 | |
Elan Rosenblat, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6290 Linton Blvd Ste 203, Delray Beach, FL 33484 Phone: 561-880-2480 Fax: 561-880-4466 | |
Dr. Kenneth R Pearlberg, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 6600 W Atlantic Ave, Unit A, Delray Beach, FL 33446 Phone: 561-637-4776 Fax: 561-637-4518 |